We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
PhRMA Senior Vice President Ken Johnson released the following statement regarding a proposed new prescription drug program for California: "America's pharmaceutical research companies are committed to developing real world, workable public policy solutions to help reduce the number of uninsured and help those with low incomes better afford their medicines.
Gardant Pharmaceuticals announced it has signed an agreement to be acquired by Switch Pharma Ltd. Shares of Switch Pharma Ltd., which is currently in the process of going public in London, will be issued to acquire Gardant Pharmaceuticals.
BioMarin Pharmaceutical Inc. announced that Orapred ODT (prednisolone sodium phosphate orally disintegrating tablets), the first FDA-approved orally disintegrating tablet form of prednisolone, is now commercially available in the United States.
The pharmaceutical industry quietly footed the bill for at least part of a recent multimillion-dollar ad campaign praising lawmakers who support the new Medicare prescription drug benefit, according to political officials.
Luitpold Pharmaceuticals, Inc. and the FDA notified healthcare professionals of a voluntary recall of additional lots of Hydralazine HCl Injection (20 mg/mL, 1 mL single dose vials) because the products may contain particulates.
President Bush will soon name John Niederhuber the next director of the National Cancer Institute (NCI), taking the place of the nominee to run the FDA, Andrew von Eschenbach.
A senator with a background in women's health says Plan B should not be distributed OTC because the drug is a much stronger version of regular birth control, which requires a prescription.